Related Experiment Video
Updated: May 12, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based
Insights
Ankylosing spondylitis (AS) patients face a higher risk of cardiovascular and cerebrovascular death. Early screening and management of vascular risk factors are crucial for this population.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory spinal arthritis prevalent in young adults.
- AS is linked to increased cardiovascular and cerebrovascular morbidity.
Purpose of the Study:
- To investigate the association between ankylosing spondylitis and the risk of cardiovascular and cerebrovascular mortality.
- To identify independent risk factors for vascular mortality in AS patients.
Main Methods:
- A population-based retrospective cohort study was conducted using administrative health data in Ontario, Canada.
- 21,473 AS patients were compared with 86,606 matched controls without AS.
- Vascular death outcomes were analyzed using hazard ratios, adjusted for multiple comorbidities and medications.
Main Results:
- Patients with AS exhibited a 36% increased risk of vascular death (HR 1.36, 95% CI 1.13-1.65).
- Increased risk was observed in men (HR 1.46) but not significantly in women (HR 1.24).
- Key risk factors included older age, male sex, lower income, dementia, chronic kidney disease, and peripheral vascular disease.
Conclusions:
- Ankylosing spondylitis is associated with a significantly elevated risk of vascular mortality.
- The study highlights the need for comprehensive strategies to screen and manage modifiable vascular risk factors in AS patients.
- A limitation noted was the lack of validation for AS diagnosis codes in the data source.
Background:
Ankylosing spondylitis (AS) is a chronic inflammatory arthritis affecting the spine in young adults. It is associated with excess cardiovascular and cerebrovascular morbidity.
Objective:
To determine whether patients with AS are at increased risk for cardiovascular and cerebrovascular mortality.
Design:
Population-based retrospective cohort study using administrative health data.
Setting:
Ontario, Canada.
Patients:
21 473 patients with AS aged 15 years or older and 86 606 comparators without AS, matched for age, sex, and location of residence.
Measurements:
The primary outcome was a composite of cardiovascular and cerebrovascular death. Hazard ratios (HRs) for vascular death were calculated; adjusted for history of cancer, diabetes, dementia, inflammatory bowel disease, hypertension, chronic kidney disease, and peripheral vascular disease; and, among those aged 66 years or older, relevant drug therapies. Independent risk factors for vascular mortality were identified in patients with AS.
Results:
The mean age of patients with AS was 46 years, and 53% were male. Patients and comparators were followed for 166 920 and 686 461 patient-years, respectively. Adjusted HRs for vascular death in AS were 1.36 (95% CI, 1.13 to 1.65) overall, 1.46 (CI, 1.13 to 1.87) in men, and 1.24 (CI, 0.92 to 1.67) in women. Significant risk factors for vascular death were age; male sex; lower income; dementia; chronic kidney disease; peripheral vascular disease; and, among patients aged 65 years or older, lack of exposure to nonsteroidal anti-inflammatory drugs and statins.
Limitation:
Diagnosis codes for AS were not validated in Ontario.
Conclusion:
Ankylosing spondylitis is associated with increased risk for vascular mortality. A comprehensive strategy to screen and treat modifiable vascular risk factors in AS is needed.
Primary Funding Source:
The Arthritis Program, University Health Network, Toronto; and The Arthritis Society, Canada.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

